Fungal infections in neutropenia: Current problems and chemotherapeutic control

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue SUPPL. D, 1998, Pages 95-105

  Warnock, David W ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; LIPOSOME; NYSTATIN; TRIAZOLE;

ASPERGILLUS; CANDIDA; FUSARIUM; HUMAN; INFECTION CONTROL; MYCOSIS; NEPHROTOXICITY; NEUTROPENIA; ORAL DRUG ADMINISTRATION; REVIEW; TRICHOSPORON;

EID: 0031748151     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.suppl_4.95     Document Type: Review

References (117)

1. Schwartz, R. S., Mackintosh, F. R., Schrier, S. L. & Greenberg, P. L. (1984). Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia. Cancer 53, 411-9.
2. Wiley, J. M., Smith, N., Leventhal, B. G., Graham, M. L., Strauss, L. C., Hurwitz, C. A. et al. (1990). Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. Journal of Clinical Oncology 8, 280-6.
3. Guiot, H. F. L., Fibbe, W. E. & van't Wout, J. W. (1994). Risk factors for fungal infection in patients with malignant hematologic disorders: implications for empirical therapy and prophylaxis. Clinical Infectious Diseases 18, 525-32.
4. Bow, E. J., Loewen, R., Cheang, M. S. & Schacter, B. (1995). Invasive fungal disease in adults undergoing remission-induction therapy for acute myeloid leukemia: the pathogenetic role of the antileukemic regimen. Clinical Infectious Diseases 21, 361-9.
5. Pirsch, J. D. & Maki, D. G. (1986). Infectious complications in adults with bone marrow transplantation and T-cell depletion of donor marrow. Increased susceptibility to fungal infections. Annals of Internal Medicine 104, 619-31.
6. Tollemar, J., Ringden, O., Bostrom, L., Nilsson, B. & Sundberg, B. (1989). Variables predicting deep fungal infections in bone marrow transplant recipients. Bone Marrow Transplantation 4, 635-41.
7. Goodrich, J. M., Reed, E. C., Mori, M., Fisher, L. D., Skerrett, S., Dandliker, P. S. et al. (1991). Clinical features and analysis of risk factors for invasive candidal infection after marrow transplantation. Journal of Infectious Diseases 164, 731-40.
8. Morrison, V. A., Haake, R. J. & Weisdorf, D. J. (1994). Non-Candida fungal infections after bone marrow transplantation: risk factors and outcome. American Journal of Medicine 96, 497-503.
9. Meyers, J. D. & Atkinson, K. (1983). Infection in bone marrow transplantation. Clinics in Haematology 12, 791-811.
10. Hunter, A. E., Haynes, A. P. & Russell, N. H. (1995). Bone marrow transplantation: current situation, complications and prevention. Journal of Antimicrobial Chemotherapy 36, Suppl. B, 119-33.
11. Mahoney, D. H., Steuber, C. P., Starling, K. A., Barrett, F. F., Goldberg, J. & Fernbach, D. J. (1979). An outbreak of aspergillosis in children with acute leukemia. Journal of Pediatrics 95, 70-2.
12. Perraud, M., Piens, M. A., Nicoloyannis, N., Girard, P., Sepetjan, M. & Garin, J. P. (1987). Invasive nosocomial pulmonary aspergillosis: risk factors and hospital building works. Epidemiology and Infection 99, 407-12.
13. Ruutu, P., Valtonen, V., Tiitanen, L., Elonen, E., Volin, L., Veijalainen, P. et al. (1987). An outbreak of invasive aspergillosis in a haematologic unit. Scandinavian Journal of Infectious Diseases 19, 347-51.
14. Reagan, D. R., Pfaller, M. A., Hollis, R. J. & Wenzel, R. P. (1990). Characterization of the sequence of colonization and nosocomial candidemia using DNA fingerprinting and a DNA probe. Journal of Clinical Microbiology 28, 2733-8.
15. Lecciones, J. A., Lee, J. W., Navarro, E. E., Witebsky, F. G., Marshall, D., Steinberg, S. M. et al. (1992). Vascular catheterassociated fungemia in patients with cancer: analysis of 155 episodes. Clinical Infectious Diseases 14, 875-83.
16. Haron, E., Feld, R., Tuffnell, P., Patterson, B., Hasselback, R. & Matlow, A. (1987). Hepatic candidiasis: an increasing problem in immunocompromised patients. American Journal of Medicine 83, 17-26.
17. Thaler, M., Pastakia, B., Shawker, T. H., O'Leary, T. & Pizzo, P. A. (1988). Hepatic candidiasis in cancer patients: the evolving picture of the syndrome. Annals of Internal Medicine 108, 88-100.
18. Wingard, J. R., Merz, W. G. & Saral, R. (1979). Candida tropicalis: a major pathogen in immunocompromised patients. Annals of Internal Medicine 91, 539-43.
19. Horn, R., Wong, B., Kiehn, T. E. & Armstrong, D. (1985). Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Reviews of Infectious Diseases 7, 646-55.
20. Komshian, S. V., Uwaydah, A. K., Sobel, J. D. & Crane, L. R. (1989). Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Reviews of Infectious Diseases 11, 379-90.
21. Martino, P., Girmenia, C., Venditti, M., Micozzi, A., Santilli, S., Burgio, V. L. et al. (1989). Candida colonization and systemic infection in neutropenic patients. A retrospective study. Cancer 64, 2030-4.
22. Sandford, G. R., Merz, W. G., Wingard, J. R., Charache, P. & Saral, R. (1980). The value of fungal surveillance cultures as predictors of systemic fungal infections. Journal of Infectious Diseases 142, 503-9.
23. Pfaller, M., Cabezudo, I., Koontz, F., Bale, M. & Gingrich, R. (1987). Predictive value of surveillance cultures for systemic infection due to Candida species. European Journal of Clinical Microbiology 6, 628-33.
24. Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E. & Saral, R. (1991). Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. New England Journal of Medicine 325, 1274-7.
25. Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H. et al. (1992). A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. New England Journal of Medicine 326, 845-51.
26. Casasnovas, R. O., Caillot, D., Solary, E., Bonotte, B., Chavanet, P., Bonin, A. et al. (1992). Prophylactic fluconazole and Candida krusei infection. New England Journal of Medicine 326, 891-2.
27. Chandrasekar, P. H., Gatny, C. M. and the Bone Marrow Transplantation Team. (1994). The effect of fluconazole prophylaxis on fungal colonization in neutropenic cancer patients. Journal of Antimicrobial Chemotherapy 33, 309-18.
28. Johnson, E. M., Davey, K. G., Szekely, A. & Warnock, D. W. (1995). Itraconazole susceptibilities of fluconazole susceptible and resistant isolates of five Candida species. Journal of Antimicrobial Chemotherapy 36, 787-93.
29. Philpott-Howard, J. N., Wade, J. J., Mufti, G. J., Brammer, K. W. & Ehninger, G. (1993). Randomized comparison of oral fluconazole versus oral polyenes for the prevention of fungal infection in patients at risk of neutropenia. Multicentre Study Group. Journal of Antimicrobial Chemotherapy 31, 973-84.
30. Merz, W. G. (1984). Candida lusitaniae: frequency of recovery, colonization, infection, and amphotericin B resistance. Journal of Clinical Microbiology 20, 1194-5.
31. Blinkhorn, R. J., Adelstein, D. & Spagnuolo, P. J. (1989). Emergence of a new opportunistic pathogen, Candida lusitaniae. Journal of Clinical Microbiology 27, 236-40.
32. Gerson, S. L., Talbot, G. H., Hurwitz, S., Strom, B. L., Lusk, E. J. & Cassileth, P. A. (1984). Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Annals of Internal Medicine 100, 345-51.
33. Nolard, N., Detandt, M. & Beguin, H. (1988). Ecology of Aspergillus species in the human environment. In Aspergillus and Aspergillosis (Vanden Bossche, H., Mackenzie, D. W. R. & Cauwenbergh, G., Eds), pp. 35-41. Plenum Press, New York.
34. Rotstein, C., Cummings, K. M., Tidings, J., Killion, K., Powell, E., Gustafson, T. L. et al. (1985). An outbreak of invasive aspergillosis among allogeneic bone marrow transplants: a case-control study. Infection Control 6, 347-55.
35. Sherertz, R. J., Belani, A., Kramer, B. S., Elfenbein, G. J., Weiner, R. S., Sullivan, M. L. et al. (1987). Impact of air filtration on nosocomial Aspergillus infections. American Journal of Medicine 83, 709-18.
36. Robertson, M. J. & Larsen, R. A. (1988). Recurrent fungal pneumonias in patients with acute nonlymphocytic leukemia under-going multiple courses of intensive chemotherapy. American Journal of Medicine 84, 233-9.
37. Karp, J. E., Burch, P. A. & Merz, W. G. (1988). An approach to intensive antileukemia therapy in patients with previous invasive aspergillosis. American Journal of Medicine 85, 203-6.
38. Orr, D. P., Myerowitz, R. L. & Dubois, P. J. (1978). Pathoradiologic correlation of invasive pulmonary aspergillosis in the compromised host. Cancer 41, 2028-39.
39. Kuhlman, J. E., Fishman, E. K. & Siegelman, S. S. (1985). Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 157, 611-4.
40. Nalesnik, M. A., Myerowitz, R. L., Jenkins, R., Lenkey, J. & Herbert, D. (1980). Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. Journal of Clinical Microbiology 11, 370-6.
41. Treger, T. R., Visscher, D. W., Bartlett, M. S. & Smith, J. W. (1985). Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures. Journal of Infectious Diseases 152, 572-6.
42. Albelda, S. M., Talbot, G. H., Gerson, S. L, Miller, W. T. & Cassileth, P. A. (1984). Role of fiberoptic bronchoscopy in the diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. American Journal of Medicine 76, 1027-34.
43. Kahn, F. W., Jones, J. M. & England, D. M. (1986). The role of bronchoalveolar lavage in the diagnosis of invasive pulmonary aspergillosis. American Journal of Clinical Pathology 86, 518-23.
44. Aisner, J., Murillo, J., Schimpft, S. C. & Steere, A. C. (1979). Invasive aspergillosis in acute leukaemia: correlation with nose cultures and antibiotic use. Annals of Internal Medicine 90, 4-9.
45. Kramer, B. S., Pizzo, P. A., Robichaud, K. J., Witesbsky, F. & Wesley, R. (1982). Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia. American Journal of Medicine 72, 561-8.
46. Rhame, F. S., Streifel, A. J., Kersey, J. H. & McGlave, P. B. (1984). Extrinsic risk factors for pneumonia in the patient at high risk of infection. American Journal of Medicine 76, Suppl. 5A, 42-52.
47. Walsh, T. J., Hier, D. B. & Caplan, L. R. (1985). Aspergillosis of the central nervous system: clinicopathological analysis of 17 patients. Annals of Neurology 18, 574-82.
48. Allan, B. T., Patton, D., Ramsey, N. K. C. & Day, D. L. (1988). Pulmonary fungal infections after bone marrow transplantation. Pediatric Radiology 18, 118-22.
49. Parfrey, N. A. (1986). Improved diagnosis and prognosis of mucormycosis: a clinicopathologic study of 33 cases. Medicine 65, 113-23.
50. Greenberg, M. R., Lippman, S. M., Grinnell, V. S., Colman, M. F. & Edwards, J. E. (1985). Computed tomographic findings in orbital mucor. Western Journal of Medicine 143, 102-3.
51. Tedder, M., Spratt, J. A., Anstadt, M. P., Hegde, S. S., Tedder, S. D. & Lowe, J. E. (1994). Pulmonary mucormycosis: results of medical and surgical therapy. Annals of Thoracic Surgery 57, 1044-50.
52. Rozich, J., Oxendine, D., Heffner, J. & Brzezinski, W. (1989). Pulmonary zygomycosis: a cause of positive lung scan diagnosed by bronchoalveolar lavage. Chest 95, 238-40.
53. Ingram, C. W., Sennesh, J., Cooper, J. N. & Perfect, J. R. (1989). Disseminated zygomycosis: report of four cases and review. Reviews of Infectious Diseases 11, 741-54.
54. Anaissie, E., Kantarjian, H., Ro, J., Hopfer, R., Rolston, K., Fainstein, V. et al. (1988). The emerging role of Fusarium infections in patients with cancer. Medicine 67, 77-83.
55. Merz, W. G., Karp, J. E., Hoagland, M., Jett-Goheen, M., Junkins, J. M. & Hood, A. F. (1988). Diagnosis and successful treatment of fusariosis in the compromised host. Journal of Infectious Diseases 158, 1046-55.
56. Richardson, S. E., Bannatyne, R. M., Summerbell, R. C., Milliken, J., Gold, R. & Weitzman, S. S. (1988). Disseminated fusarial infection in the immunocompromised host. Reviews of Infectious Diseases 10, 1171-81.
57. Garnis, A. S., Gudnason, T., Giebink, G. S. & Ramsay, N. K. C. (1991). Disseminated infection with Fusarium in recipients of bone marrow transplants. Reviews of Infectious Diseases 13, 1077-88.
58. Girmenia, C., Arcese, W., Micozzi, A., Martino, P., Bianco, P. & Morace, G. (1992). Onychomycosis as a possible origin of disseminated Fusarium solani infection in a patient with severe aplastic anemia. Clinical Infectious Diseases 14, 1167.
59. Nelson, P. E., Dignani, M. C. & Anaissie, E. J. (1994). Taxonomy, biology, and clinical aspects of Fusarium species. Clinical Microbiology Reviews 7, 479-504.
60. Marin, J., Sanz, M. A., Sanz, G. F., Guarro, J., Martinez, M. L., Prieto, M. et al. (1991). Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia. European Journal of Clinical Microbiology & Infectious Diseases 10, 759-61.
61. Salesa, R., Burgos, A., Ondiviela, R., Richard, C., Quindos, G. & Ponton, J. (1993). Fatal disseminated infection by Scedosporium inflatum after bone marrow transplantation. Scandinavian Journal of Infectious Diseases 25, 389-93.
62. Madrigal, V., Alonso, J., Bureo, E., Figols, F. J. & Salesa, R. (1995). Fatal meningoencephalitis caused by Scedosporium inflatum (Scedosporium prolificans) in a child with lymphoblastic leukemia. European Journal of Clinical Microbiology & Infectious Diseases 14, 601-3.
63. Lutwick, L. I., Galgiani, J. N., Johnson, R. H. & Stevens, D. A. (1976). Visceral fungal infections due to Petriellidium boydii (Allescheria boydii). In vitro drug sensitivity studies. American Journal of Medicine 61, 632-40.
64. Hopwood, V., Evans, E. G. V., Matthews, J. & Denning, D. W. (1995). Scedosporium prolificans, a multi-resistant fungus, from a UK AIDS patient. Journal of Infection 30, 153-5.
65. Walsh, T. J., Newman, K. R., Moody, M., Wharton, R. C. & Wade, J. C. (1986). Trichosporonosis in patients with neoplastic disease. Medicine 65, 268-79.
66. Walling, D. M., McGraw, D. J., Merz, W. G., Karp, J. E. & Hutchins, G. M. (1987). Disseminated infection with Trichosporon beigelii. Reviews of Infectious Diseases 9, 1013-9.
67. Martino, P., Venditti, M., Micozzi, A., Morace, G., Polonelli, L., Mantovani, M. P. et al. (1990). Blastoschizomyces capitatus: an emerging cause of invasive fungal disease in leukemia patients. Reviews of Infectious Diseases 12, 570-82.
68. Walsh, T. J., Melcher, G. P., Rinaldi, M. G., Lecciones, J., McGough, D. A., Kelly, P. et al. (1990). Trichosporon beigelii, an emerging pathogen resistant to amphotericin B. Journal of Clinical Microbiology 28, 1616-22.
69. Pizzo, P. A., Robichaud, K. J., Gill, F. A. & Witebsky, F. G. (1982). Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. American Journal of Medicine 72, 101-11.
70. EORTC International Antimicrobial Therapy Cooperative Group. (1989). Empiric antifungal therapy in febrile granulocytopenic patients. American Journal of Medicine 86, 668-72.
71. Walsh, T. J., Lee, J., Lecciones, J., Rubin, M., Butler, K., Francis, P. et al. (1991). Empiric therapy with amphotericin B in febrile granulocytopenic patients. Reviews of Infectious Diseases 13, 496-503.
72. Burch, P. A., Karp, J. E., Merz, W. G., Kuhlman, J. E. & Fishman, E. K. (1987). Favorable outcome of invasive aspergillosis in patients with acute leukemia. Journal of Clinical Oncology 5, 1985-93.
73. Ellis, M. E., Halim, M. A., Spence, D., Ernst, P., Clink, H., Kalin, M. et al. (1995). Systemic amphotericin B versus fluconazole in the management of antibiotic resistant neutropenic fever: preliminary observations from a pilot, exploratory study. Journal of Infection 30, 141-6.
74. Meunier, F., Prentice, H. G. & Ringden, O. (1991). Liposomal amphotericin B (AmBisome): safety data from a phase II/III clinical trial. Journal of Antimicrobial Chemotherapy 28, Suppl. B., 83-91.
75. Ringden, O., Andstrom, E., Remberger, M., Svahn, B. M. & Tollemar, J. (1994). Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin. Bone Marrow Transplantation 14, Suppl. 5, S10-4.
76. Kline, S., Larsen, T. A., Fieber, L., Fishbach, R., Greenwood, M., Harris, R. et al. (1995). Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complex. Clinical Infectious Diseases 21, 1154-8.
77. Oppenheim, B. A., Herbrecht, R. & Kusne, S. (1995). The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. Clinical Infectious Diseases 21, 1145-53.
78. Mills, W., Chopra, R., Linch, D. C. & Goldstone, A. H. (1994). Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single-centre experience of 133 episodes in 116 patients. British Journal of Haematology 86, 754-60.
79. Hiemenz, J. W., Anaissie, E. & Walsh, T. J. (1994). Amphotericin B lipid complex for the treatment of severe systemic mycosis in patients with haematologic malignancies. In Abstracts of the Thirty Sixth Annual Meeting of the American Society of Hematology, Nashville, TN, 1994. Abstract 1207. American Society of Hematology, Washington, DC.
80. Anaissie, E. J., White, M., Uzun, O., Singer, C., Bodey, G. P., Matzke, D. et al. (1995). Amphotericin B lipid complex (ABLC) versus amphotericin B (AMB) for treatment of hematogenous and invasive candidiasis: a prospective, randomized, multicenter trial. In Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, CA, 1995. Abstract LM21, p. 330. American Society for Microbiology, Washington, DC.
81. Viviani, M. A., Cofrancesco, E., Boschetti, C., Tortorano, A. M. & Cortellaro, M. (1991). Eradication of Fusarium infection in a leukopenic patient treated with liposomal amphotericin B. Mycoses 34, 255-6.
82. Engelhard, D., Eldor, A., Polacheck, I., Hardan, I., Ben-Yehuda, D., Anselem, S. et al. (1993). Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. Leukemia and Lymphoma 9, 385-92.
83. Wolff, M. A. & Ramphal, R. (1995). Use of amphotericin B lipid complex for treatment of disseminated cutaneous fusarium infection in a neutropenic patient. Clinical Infectious Diseases 20, 1568-9.
84. Mustafa, M. M., Sandler, E. S., Bernini, J. C. & Aquino, V. M. (1994). Amphotericin B colloidal dispersion therapy for invasive mycosis: report of successful therapy in two pediatric patients. Pediatric Infectious Disease Journal 13, 326-8.
85. Akova, M., Akalin, H. E., Uzun, O., Hayran, M., Tekuzman, G., Kansu, E. et al. (1994). Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome. Clinical Infectious Diseases 18, 298-304.
86. Anaissie, E., Bodey, G. P., Kantarjian, H., David, C., Barnett, K., Bow, E. et al. (1991). Fluconazole therapy for chronic disseminated candidiasis in patients with leukemia and prior amphotericin B therapy. American Journal of Medicine 91, 142-50.
87. Kauffman, C. A., Bradley, S. F., Ross, S. C. & Weber, D. R. (1991). Hepatosplenic candidiasis: successful treatment with fluconazole. American Journal of Medicine 91, 137-41.
88. Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van Der Horst, C. M., Edwards, J. E. et al. (1994). A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. New England Journal of Medicine 331, 1325-30.
89. Persons, D. A., Laughlin, M., Tanner, D., Perfect, J., Gockerman, J. P. & Hathorn, J. W. (1991). Fluconazole and Candida krusei fungemia. New England Journal of Medicine 325, 1315.
90. Meis, J. F., Donnelly, J. P., Hoogkamp-Korstanje, J. A. & De Pauw, B. E. (1993). Aspergillus fumigatus pneumonia in neutropenic patients during therapy with fluconazole for infection due to Candida species. Clinical Infectious Diseases 16, 734-5.
91. Anaissie, E. J., Kontoyiannis, D. P., Huls, C., Vartivarian, S. E., Karl, C., Prince, R. A. et al. (1995). Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections. Journal of Infectious Diseases 172, 599-602.
92. van't Wout, J. W. (1992). Itraconazole in neutropenic patients. Chemotherapy (Basel) 38, Suppl. 1, 23-6.
93. Denning, D. W., Tucker, R. M., Hanson, L. H. & Stevens, D. A. (1989). Treatment of invasive aspergillosis with itraconazole. American Journal of Medicine 86, 791-800.
94. Denning, D. W., Lee, J. Y., Hostetler, J. S., Pappas, P., Kauffman, C. A., Dewsnup, D. H. et al. (1994). NIAID Mycoses Study Group multicenter trial of oral itraconazole therapy for invasive aspergillosis. American Journal of Medicine 97, 135-44.
95. Dupont, B. (1990). Itraconazole therapy in aspergillosis: study in 49 patients. Journal of the American Academy of Dermatology 23, 607-14.
96. Bradford, C. R., Prentice, A. G., Warnock, D. W. & Copplestone, J. A. (1991). Comparison of the multiple dose pharmacokinetics of two formulations of itraconazole during remission induction for acute myeloblastic leukaemia. Journal of Antimicrobial Chemotherapy 28, 555-60.
97. Persat, F., Marzullo, C., Guyotat, D., Rochet, M. J. & Piens, M. A. (1992). Plasma itraconazole concentrations in neutropenic patients after repeated high-dose treatment. European Journal of Cancer 28A, 838-41.
98. Prentice, A. G., Warnock, D. W., Johnson, S. A. N., Phillips, M. J. & Oliver, D. A. (1994). Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients. Journal of Antimicrobial Chemotherapy 34, 247-52.
99. Prentice, A. G., Warnock, D. W., Johnson, S. A. N., Taylor, P. C. & Oliver, D. A. (1995). Multiple dose pharmacokinetics of an oral solution of itraconazole in patients receiving chemotherapy for acute myeloid leukaemia. Journal of Antimicrobial Chemotherapy 36, 657-63.
100. Armstrong, D. (1984). Protected environments are discomforting and expensive and do not offer meaningful protection. American Journal of Medicine 76, 685-9.
101. Hopkins, C. C., Weber, D. J. & Rubin, R. H. (1989). Invasive aspergillus infection: possible non-ward common source within the hospital environment. Journal of Hospital Infection 13, 19-25.
102. Allo, M. D., Miller, J., Townsend, T. & Tan, C. (1987). Primary cutaneous aspergillosis associated with Hickman intravenous catheters. New England Journal of Medicine 317, 1105-8.
103. Ellis, M. E., Clink, H., Ernst, P., Halim, M. A., Padmos, A., Spence, D. et al. (1994). Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients. European Journal of Clinical Microbiology & Infectious Diseases 13, 3-11.
104. Slavin, M. A., Osborne, B., Adams, R., Levenstein, M. J., Schoch, H. G., Feldman, A. R. et al. (1995). Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation: a prospective, randomized, double-blind study. Journal of Infectious Diseases 171, 1545-52.
105. Winston, D. J., Chandrasekar, P. H., Lazarus, H. M., Goodman, J. L., Silber, J. L., Horowitz, H. et al. (1993). Fluconazole prophylaxis of fungal infections in patients with acute leukemia. Results of a randomized placebo-controlled, double-blind, multicenter trial. Annals of Internal Medicine 118, 495-503.
106. Bodey, G. P., Anaissie, E. J., Elting, L. S., Estey, E., O'Brien, S. & Kantarjian, H. (1994). Antifungal prophylaxis during remission induction therapy for acute leukemia: fluconazole versus intravenous amphotericin B. Cancer 73, 2099-106.
107. Vreugdenhil, G., Van Dijke, B. J., Donnelly, J. P., Novakova, I. R. O., Raemaekers, J. M. M., Hoogkamp-Korstanje, M. A. A. et al. (1993). Efficacy of itraconazole in the prevention of fungal infections among neutropenic patients with hematologic malignancies and intensive chemotherapy. A double blind, placebo controlled study. Leukemia and Lymphoma 11, 353-8.
108. Tricot, G., Joosten, E., Boogaerts, M. A., Vande Pitte, J. & Cauwenbergh, G. (1987). Ketoconazole vs. itraconazole for anti-fungal prophylaxis in patients with severe granulocytopenia: preliminary results of two nonrandomized studies. Reviews of Infectious Diseases 9, Suppl. 1, S94-9.
109. Brincker, H., Christensen, B. E., Schmidt, K. G. & Hornstrup, M. K. (1991). Itraconazole treatment of pulmonary aspergillosis in leukaemia patients during a nosocomial epidemic associated with indoor building renovation. Mycoses 34, 395-400.
110. Working Party of the British Society for Antimicrobial Chemotherapy. (1993). Chemoprophylaxis for candidosis and aspergillosis in neutropenia and transplantation: a review and recommendations. Journal of Antimicrobial Chemotherapy 32, 5-21.
111. Rousey, S. R., Russler, S., Gottlieb, M. & Ash, R. C. (1991). Low-dose amphotericin B prophylaxis against invasive Aspergillus infections in allogeneic marrow transplantation. American Journal of Medicine 91, 484-92.
112. Perfect, J., Klotman, M. E., Gilbert, C. C., Crawford, D. D., Rosner, G. L., Wright, K. A. et al. (1992). Prophylactic intravenous amphotericin B in neutropenic autologous bone marrow transplant recipients. Journal of Infectious Diseases 165, 891-7.
113. Tollemar, J., Ringden, O., Andersson, S., Sundberg, B., Ljungman, P., Sparrelid, E. et al. (1993). Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients. Transplantation Proceedings 25, 1495-7.
114. Meunier-Carpentier, F., Snoeck, R., Gerain, J., Muller, C. & Klastersky, J. (1984). Amphotericin B nasal spray as prophylaxis against aspergillosis in patients with neutropenia. New England Journal of Medicine 311, 1056.
115. Meunier, F. (1987). Prevention of mycoses in immunocompromised patients. Reviews of Infectious Diseases 9, 408-16.
116. Jeffery, G. M., Beard, M. E. J., Ikram, R. B., Chua, J., Alien, J. R., Heaton, D. C. et al. (1991). Intranasal amphotericin B reduces the frequency of invasive aspergillosis in neutropenic patients. American Journal of Medicine 90, 685-92.
117. Conneally, E., Cafferkey, M. T., Daly, P. A., Keane, C. T. & McCann, S. R. (1990). Nebulized amphotericin B as prophylaxis against invasive aspergillosis in granulocytopenic patients. Bone Marrow Transplantation 5, 403-6.